39results about How to "Providing therapy" patented technology

A personal wellness system may facilitate personal wellness management via personal wellness devices. The personal wellness devices may be portable, handheld devices configured to facilitate personal exercise and personal wellness management using the device. Exercises performed using the personal wellness devices may be tracked based on forces exerted on the personal wellness device, a location and/or motion of the personal wellness device, and/or other bases for tracking personal exercise. Tracked exercises may be a basis for determining exercise parameters such as information associated with cardiovascular endurance, respiratory endurance, stamina, strength, flexibility, power, speed, coordination, agility, and/or balance; calories burnt or energy expended; a completion level of a prescribed exercise routine; a quantified improvement in an exercise; and/or other exercise parameters. The personal wellness system may facilitate automated and/or live coaching, exercise regimen design, exercise scheduling, diet program design, rehabilitation, and/or other functions associated with personal wellness management.

Method and system to provide therapy for obesity, gastric motility, or to induce weight loss comprises ablating the gastric tissue around the “pacemaker” region of the stomach, and electrically pacing the stomach with a pulse generator/stimulator to control the electrical activity of the gastric muscle. The ablation to the gastric tissue may be from the epigastric side, or may be from inside the stomach. The ablation may be performed utilizing any one of: radiofrequency catheter ablation; radiofrequency catheter ablation using an irrigated tip catheter; microwave ablation; cryoablation; high intensity focused ultrasound (HIFU) ablation; and laser ablation. The ablation of the “pacemaker” region of the stomach may be partial or complete. A gastric pulse generator/stimulator is implanted to provide electrical pulses to the stomach. The function of the gastric stimulator after complete ablation of the pacemaker region, is to provide a basic electrical rhythm (BER) to regulate and control electrical activity of the stomach. Alternatively, if partial ablation is performed the function of the gastric pulse generator/stimulator is to enhance the residual basic electrical rhythm (BER), or to interfere with the residual basic electrical rhythm (BER).

A publically available external defibrillator includes a detector used to detect a life threatening condition of a patient, a controller operating the defibrillator automatically and a therapy delivery circuit that delivers appropriate therapy. The defibrillator is attached to a patient by any attendant or bystander and once it is attached, the defibrillator is adapted to monitor the patient and when a life threatening condition is detected, to apply therapy automatically, i.e., without any involvement by the patient or the attendant.

The present invention provides a motorized foot caring and massage device(MFCMD), comprising a container provided in a housing, the container having a bottom portion and used for containing water; an air pump, heating means, a vibration assembly and a motorized driven system being provided under the bottom portion of the container; and a function selection switch provided on the housing, in which an upwardly raised peninsular foot seat is provided at a central portion of the container, a combination of stone massage means and raised nodes is provided at a front end of a top portion of the foot seat, and replaceable rotatable massage attachments are provided at a rear end of the top portion of the foot seat; a double safety system is provided under the bottom portion of the container, including a sealing system and a drainage system, the sealing system is used for maintaining the rotation of the output shaft and sealing under normal condition, the drainage system is used for preventing water contained in the container from leaking and entering into the means provided under the bottom of the container in case of failure of the sealing system. The foot caring and massage device of the present invention perfects the functions and guarantees safe and reliable operation.

A personal nebulizer or vaporizing unit with a mouthpiece, which may be detachable and replaceable. The mouthpiece includes an orifice through which vapor is emitted. The substance to be vaporized is contained in an ampoule inserted into the device, where the substance enters an atomization chamber where vaporization is achieved through piezoelectric transducers or atomizers providing sonic or ultrasonic vibration. The substance includes a variety of therapeutic, homeopathic, or naturopathic formulations, remedies, or serums. One or more light sources, vibrational sources, heating sources or elements, piezo transducers, or combinations thereof, may be provided on the mouthpiece or a portion of the device inserted into the mouth.

A thermal glove for providing warmth to a hand of the user includes a top section for covering a top of the thermal glove, a bottom section for covering a bottom of the thermal glove, a heating element positioned between the top section and the bottom section for heating the interior of the thermal glove, and a temperature control device to control the heating element to control the interior temperature of the thermal glove. The temperature control device may be a variable temperature control device, and the thermal glove includes a controller circuit for controlling the heating element. The thermal glove includes a battery circuit for providing power to the heating element, and the thermal glove includes a charging circuit for charging the battery circuit. The battery circuit may be connected to a knife connection device, and the battery circuit may be connected to an A/C connector device.

The present invention relates to methods of fitting for pre-fabricated compression garments via digital imaging of a wearer body part and measurement of body part circumferences and, optionally, lengths therefrom. The present invention also relates to methods of generating a shape description derived from digital imaging of a patient body part or body area of interest and use of such shape description. Such shape description includes geometric information from which measurement information can optionally be derived. Included herein are methods for diagnosing and monitoring edema and other conditions in patients using shape descriptions acquired from a patient in need of such diagnosis and monitoring. The invention also includes use of the generated shape descriptions to make compression garments specifically configured for a patient's body part or body area. Compression garments generated from the generated shape descriptions are also included herein.

The present invention relates to methods of generating a shape description from digital image acquisition for a patient body part or body area of interest and use of such shape description. Such shape description includes geometric information from which measurement information can optionally be derived. Included herein are methods for diagnosing and monitoring edema and other conditions in patients using shape descriptions acquired from a patient in need of such diagnosis and monitoring. The invention also includes use of the generated shape descriptions to make compression garments specifically configured for a patient's body part or body area. Compression garments generated from the shape descriptions are also included herein.

A lumbar orthosis, comprising a rigid thermoplastic plate molded to the contours of the patient's back and at least one permanent magnet located on the orthosis that can provide magnetic therapy for patients with severe back problems, and further comprising adjustable supplementary fasteners that enable the patient to tighten or loosen the orthosis without removing it.

Disclosed are thermally-activatable liposomal compositions and methods for their use in the formulation and administration of therapeutic, prophylactic, and diagnostic agents. The disclosed liposome structures are capable of carrying a variety of biologically active reagents, and permitting their controlled release in vivo by exploiting properties of their thermoregulatable lability.

Toe separators for use by a diabetic patient to maintain the toes separated, even when wearing shoes, to prevent the development of sores on the toes resulting from abrasion, and to promote healing are disclosed. In a preferred embodiment, there is provided a generally flat sole insert for protecting the user's heel, wherein the insert is further provided with a plurality of upwardly projecting toe dividers for keeping the toes separated. The dividers effectively separate the user's toes to prevent rubbing while allowing the user to walk wearing shoes. In various alternate embodiments, there are disclosed individual soft toe caps that may be individually placed over one or more individual toes to protect and separate the toes. In still another alternate embodiment, the individual toe separators may be fabricated as double-wall caps formed by inner and outer layers of a soft, FDA approved silicon material, and adapted to be filled with water or other suitable liquid or a gel. According to another aspect, the present invention provides a foot protector to be worn on the foot of a patient. The foot protector preferably incorporates one or more water-filled toe protectors for separating the toes as generally described above. Each of the embodiments may define a plurality of ventilation holes formed by welding of inner and outer portions. Any of the embodiments disclosed herein may further include medicated powders to reduce friction and aid in healing ulcerations. The filled embodiments may further be cooled or heated to provide therapeutic cooling or warmth to the foot and toes.

A development toy that is made of soft, light BPA-free silicone and/or clear plastic that is one solid piece with no moving parts or attachments. The toy is intended to sooth an infant and/or toddler when frustrated from teething pains in their gum and oral area. The toy will be made in various different animal, bird, fish and machine shapes with appendages in the shape of a human female “mother's” nipple to provide the familiar sensation of sucking on mother's breast. The toy will be made in non-toxic soft materials, clear plastic and/or silicone resembling candy in bright soft pastels in a cartoon formed body with easily gripping areas. All parts of the toy provide a safe form of soothing and controlled breathing areas.

A feet massage apparatus includes a pair of foot-reception boots. A pair of liquid distribution conduits are connected to the foot-reception boots. A liquid pump is connected to the liquid distribution conduits. A pump-to-reservoir conduit is connected to the liquid pump. A liquid reservoir is connected to the pump-to-reservoir conduit. The liquid reservoir includes a quantity of foot-treating liquid. A pair of air distribution conduits are connected to the foot-reception boots. An air-conduits-to-pump hose is connected to the air distribution conduits, and an air pump is connected to the air-conduits-to-pump hose. The air pump provides air bubbles for bubbling through the foot-treating liquid in the foot-reception boots. To use the apparatus, feet are immersed in a prepared solution that is heated and is agitated by controlled air pumped into the foot-reception boots, thereby providing a soothing massaging action to the feet.

A wearable device for spinal decompression of dogs or other quadrupedal animals. The preferred embodiment of the device comprises front and rear harnesses of flexible material extending around the animal's torso, curved members attached to the front and rear harnesses and lying along the animal's body, and rigid extensible braces connected to the front and rear curved members, generally parallel to the animal's spine. The harnesses, braces, and curved members are selected or can be adjusted to fit the animal. The extensible rods are adjustable, with means to produce therapeutic decompression and support of the animal's spine between the front and rear harnesses.

Disclosed are immunogenic compositions, and methods for their use in the formulation and administration of therapeutic and prophylactic pharmaceutical agents. In particular, the invention provides immunogenic compositions and methods for preventing, treating, managing, and/or ameliorating a viral or microbial infection, or one or more symptoms thereof, including, for example, those infections giving rise to shipping fever, bovine respiratory disease complex, and/or bovine viral diarrhea, particularly in susceptible or infected animals.

A patient securing overlay is provided that includes a sheet of fabric for supporting a patient's torso on a surgical table. The sheet of fabric has an upper surface configured to face the patient and a lower surface configured to face a surgical table mattress or underbody support. The sheet of fabric includes friction enhancing elements applied to at least a portion of the upper surface thereof. The sheet of fabric can include an extension at a foot end of the sheet of fabric that provides material to be tucked under a foot end of the surgical table mattress or underbody support for securing the foot end of the sheet of fabric to the surgical table mattress or underbody support. The extension can include one or more friction enhancing elements.

A method of tolerance to narcotics in a patient in need thereof comprises administering a botulinum toxin to the patient. The botulinum toxin is selected from the group consisting of botulinum toxin type A, botulinum toxin type B, botulinum toxin type C, botulinum toxin type D, botulinum toxin type E, botulinum toxin type F and botulinum toxin type G, a fragment thereof, a hybrid thereof, a chimera thereof, and a combination thereof. The botulinum toxin may be administered by subcutaneous/intradermal injection. The subcutaneous/intradermal injection may be administered to and/or around the vicinity of a trigeminal nerve, a cervical nerve, a thoracic nerve, a lumbar nerve, and a sacral nerve of the patient. The therapeutically effective amount of the botulinum toxin administered is between about 1 unit and about 150 units.

A medical implant including an implant body for insertion into a human and/or animal body. The implant body includes at least one first and at least one second contact portion, wherein the at least one first and the at least one second contact portions contact two tissue regions performing a relative movement with respect to one another. The at least one first and the at least one second contact portions are movable relative to one another, wherein a relative movement of the contact portions may be converted into an electrical signal.

An implantable cardiac system that includes an implantable cardiac pacemaker or leadless pacemaker (iLP) and a second device such as a subcutaneous implantable cardioverter-defibrillator (S-ICD). The pacemaker includes an R-spike amplifier that amplifies stimulated ventricle excitations or R-waves to increase R-wave to T-wave signal to noise ratio and to improve indirect detection of ventricular rhythm classification by the S-ICD. The S-ICD includes an electrode line for defibrillation, a sensing unit and a stimulation detection unit. The S-ICD records a subcutaneous electrocardiogram between shock electrode poles and provides potentially life-saving therapy based thereon. The system significantly increases the specificity and sensitivity of an S-ICD in combination with an implanted cardiac pacemaker or iLP having an R-spike amplifier.

The invention relates to hexahydropentaleno derivatives, the preparation method and use in medicine thereof, and in particular to hexahydropentaleno derivatives or stereo-isomers or pharmaceutically acceptable salts thereof as shown in general formula (I), and to the preparation method therefor and pharmaceutical compositions comprising the derivatives, and to the use thereof as a therapeutical agent, especially as a DPP-IV inhibitor. The definition of each substituent in formula (I) is the same as the definition in the description.

A modified release dosage form for the oral administration of tranexamic acid.

[Problem] Providing a novel interaction between proteins.

[Solution Means] It has been found that there is an interaction between proteins between proteasome and ZNF216 (or AWP1). It has also been found that there is an interaction between proteins between a polyubiquitin chain and ZNF216 (or AWP1). By utilizing this novel interaction between the proteins, a therapeutic agent for disuse muscular atrophy, and a method for screening the therapeutic agents for disuse muscular atrophy, a marker for disease diagnosis, a method for evaluating the risk of onset of the disuse muscular atrophy, etc., are provided.